Ranpak Board Grants 25,000 RSUs to Director Amid Insider Buying Wave, Signaling Confidence in a Bearish Market

Insider Confidence in a Challenging Market

On March 3 2026, Michael S. Gliedman, a board director of Ranpak Holdings Corp., executed a sizable grant of 25,000 restricted stock units (RSUs) under the company’s 2019 Omnibus Incentive Plan. While the RSUs have no immediate cash component, they represent a commitment to future equity—three equal vesting installments slated for 2027, 2028, and 2029. In the short term, the transaction added 25,000 shares to the company’s outstanding equity, bringing Gliedman’s post‑transaction holdings to 169,263 Class A shares. The grant came at a price point of $0.00 because the shares are not immediately sold; rather, they are awarded as part of a long‑term incentive scheme. This move signals the board’s belief that Ranpak’s growth trajectory will justify the vesting of these shares over the next three years.

A Broader Insider Activity Trend

Gliedman’s transaction is part of a broader wave of insider buying that has swept Ranpak’s leadership team. Chief Operating Officer Aram Paul recently purchased 25,000 shares on the same day, and CEO/Executive Chairman Asali Omar added 92,026 shares, bringing his total holdings to 2.78 million shares. Earlier in 2025, the company’s senior executives—including Paul, Jones, Seshadri, and Tranen—also made sizeable purchases that lifted their holdings to multi‑hundred‑thousand or even multi‑million levels. This pattern of cumulative buying by insiders suggests a coordinated confidence that the company’s fundamentals will improve, despite the current steep decline in share price and negative earnings metrics.

Implications for Investors

For investors, the insider activity is a double‑edged sword. On one side, the board’s willingness to award and purchase shares signals that they expect future upside, potentially boosting investor sentiment in a period of volatility. On the other side, the market remains bearish: Ranpak’s shares closed at $5.29 on March 3, down 19.85% for the week and 31.61% year‑to‑date, with a negative price‑earnings ratio of –10.78. The company’s 52‑week high of $6.51 is still out of reach, and the negative earnings signal cautions that profitability remains elusive. The recent social‑media buzz—213.65 % higher than average—along with a negative sentiment score of –42, indicates heightened attention but also widespread skepticism among retail investors.

Looking Ahead

If the insider confidence translates into operational gains—such as cost efficiencies, stronger contract wins, or new product lines—Ranpak could begin to break out of its current downtrend. The RSU grant’s vesting schedule extends over three years, providing a built‑in incentive for the leadership to drive long‑term value. However, until the company can demonstrate consistent earnings and a positive price‑to‑earnings trajectory, the market may remain hesitant. For now, insiders appear to be betting on a turnaround, but investors should monitor both earnings releases and market reactions closely before making any decisive moves.